TABLE 1.
Data summary
| ORIEN | TCGA | P | |
|---|---|---|---|
| N | 480 | 2,993 | |
| BLCA (%) | 19 (4.0) | 414 (13.8) | |
| COAD (%) | 70 (14.6) | 478 (16.0) | |
| KIRC (%) | 20 (4.2) | 538 (18.0) | |
| LUAD (%) | 99 (20.7) | 533 (17.8) | |
| LUSC (%) | 3 (0.6) | 502 (16.8) | |
| READ (%) | 20 (4.2) | 166 (5.5) | |
| SARC (%) | 116 (24.3) | 259 (8.7) | |
| SKCM (%) | 16 (3.3) | 103 (3.4) | |
| OTHER (%) | 117 (24.4) | 0 (0.0) | |
| AGE AT COLLECTION [MEAN (SD)] | 60.13 (12.60) | 64.93 (11.83) | <0.001 |
| GENDER = MALE (%) | 275 (57.3) | 1,796 (60.1) | 0.271 |
| BMI AT COLLECTION [MEAN (SD)] | 28.67 (6.56) | 28.43 (13.44) | 0.728 |
| PRESERVATION = FROZEN (%) | 376 (78.3) | 2,962 (99.0) | <0.001 |
| OVERALL SURVIVAL (DAYS) [MEAN (SD)] | 1,569.70 (1074.73) | 762.70 (726.24) | <0.001 |
| TISSUE SOURCE = PRIMARY (%) | 314 (65.4) | 2785 (93.1) | <0.001 |
| TUMOR STAGE (%) | <0.001 | ||
| Stage 1 | 77 (16.1) | 921 (40.4) | |
| Stage 2 | 98 (20.5) | 647 (28.4) | |
| Stage 3 | 125 (26.2) | 501 (22.0) | |
| Stage 4 | 112(23.5) | 208 (9.1) |